COVID-19 infection and renal injury: where is the place for acute interstitial nephritis disease?
Author
Date
2022-09Permanent link
https://hdl.handle.net/11351/8543DOI
10.1093/ckj/sfac079
ISSN
2048-8513
WOS
000768463100001
PMID
35999963
Abstract
Novel coronavirus disease infection (coronavirus disease 2019, COVID-19) was declared a global pandemic in March 2020 and since then has become a major public health problem. The prevalence of COVID-19 infection and acute kidney injury (AKI) is variable depending on several factors such as race/ethnicity and severity of illness. The pathophysiology of renal involvement in COVID-19 infection is not entirely clear, but it could be in part explained by the viral tropism in the kidney parenchyma. AKI in COVID-19 infection can be either by direct invasion of the virus or as a consequence of immunologic response. Diverse studies have focused on the effect of COVID-19 on glomerulonephritis (GN) patients or the ‘novo’ GN; however, the effect of COVID-19 in acute tubulointerstitial nephritis (ATIN) has been scarcely studied. In this article, we present five cases with different spectrums of COVID-19 infection and ATIN that may suggest that recent diagnosis of ATIN is accompanied by a worse clinical prognosis in comparison with long-term diagnosed ATIN.
Keywords
COVID-19; Acute tubulointerstitial nephritis; Kidney biopsyBibliographic citation
León-Román J, Agraz I, Vergara A, Ramos N, Toapanta N, García-Carro C, et al. COVID-19 infection and renal injury: where is the place for acute interstitial nephritis disease?. Clin Kidney J. 2022 Sep;15(9):1698–1704.
Audience
Professionals
This item appears in following collections
- Col·lecció especial COVID-19 [945]
- HVH - Articles científics [4476]
- VHIR - Articles científics [1751]
The following license files are associated with this item:





